ERBB2 and breast carcinoma: SRC-1 may contribute to the metastatic activity of breast cancer by promoting Ets2-mediated HER2 expression and promoting the recruitment of macrophages to tumour sites by upregulating the expression of colony-stimulating factor 1 (CSF-1) [70].